Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
08.04. | Syra Health Corp - 8-K, Current Report | 4 | SEC Filings | ||
SYRA HEALTH Aktie jetzt für 0€ handeln | |||||
01.04. | Syra Health announces voluntary delisting from Nasdaq | 4 | Seeking Alpha | ||
01.04. | Syra Health to delist from Nasdaq Capital Market | 1 | Investing.com | ||
01.04. | Syra Health kündigt Rückzug vom NASDAQ Capital Market an | 2 | Investing.com Deutsch | ||
01.04. | Syra Health Announces Voluntary Delisting from the Nasdaq Capital Market | 64 | PR Newswire | CARMEL, Ind., April 1, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering... ► Artikel lesen | |
13.03. | Syra Health sichert Vertragsverlängerung im Wert von 660.000 US-Dollar | 1 | Investing.com Deutsch | ||
13.03. | Syra Health secures $660,000 population health contract extension | 1 | Seeking Alpha | ||
11.03. | Syra Health Corp - 8-K, Current Report | 2 | SEC Filings | ||
11.03. | Syra Health Corp - 10-K, Annual Report | 1 | SEC Filings | ||
11.03. | Syra Health Announces Full-Year Revenue of $8.0 Million, Up 45% YoY | 199 | PR Newswire | 2024 Population Health Revenue Acceleration to 132% YoY
Q4 2024 Net Losses Cut Nearly in Half Compared to Q4 2023, Highlighting Major Efficiency Gains
Continued... ► Artikel lesen | |
11.03. | Syra Health GAAP EPS of -$0.50, revenue of $7.98M | 1 | Seeking Alpha | ||
25.02. | Syra Health secures $450K contract extension in Tennessee | 2 | Investing.com | ||
13.02. | Syra Health sichert sich neuen Vertrag für Schulungen im Bereich psychische Gesundheit | 2 | Investing.com Deutsch | ||
24.01. | Syra Health files for $75M mixed securities shelf | 1 | Seeking Alpha | ||
17.01. | Syra Health Corp - 8-K, Current Report | - | SEC Filings | ||
07.01. | Why Is Syra Health Stock Surging Today? | 1 | Benzinga.com | ||
07.01. | Syra Health secures contracts in education, healthcare sectors | 1 | Investing.com | ||
07.01. | Syra Health sichert sich Verträge im Bildungs- und Gesundheitssektor | 1 | Investing.com Deutsch | ||
29.10.24 | Syra Health Corp - 10-Q, Quarterly Report | 3 | SEC Filings | ||
29.10.24 | Syra Health Corp - 8-K, Current Report | 1 | SEC Filings |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
SERNOVA BIOTHERAPEUTICS | 0,122 | -3,17 % | Sernova Biotherapeutics Inc: Sernova closes $4-million term loan from Navigate | ||
ATOSSA THERAPEUTICS | 0,540 | -1,46 % | Nona Biosciences and Atossa team up to discover breast cancer therapies | ||
PING AN HEALTHCARE | 0,784 | -0,03 % | Ping An Healthcare and Technology Company Limited: Ping An Health Reports First Full-Year Profit in 2024 | Synergies Between Health Care and Insurance Drive Scalable GrowthAI Innovations Fuel Continued Success
SHANGHAI and HONG KONG, March 13, 2025 /PRNewswire/ -- Ping An Healthcare and Technology... ► Artikel lesen | |
MOUNTAIN VALLEY MD | 0,016 | -22,12 % | Mountain Valley MD Holdings Inc: Mountain Valley hopes for continued growth in 2025 | ||
CO-DIAGNOSTICS | 0,278 | -2,80 % | Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results | SALT LAKE CITY, March 27, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the... ► Artikel lesen | |
CYTOSORBENTS | 0,861 | 0,00 % | Cytosorbents Corp - 8-K, Current Report | ||
VERU | 0,470 | -0,21 % | Veru Aktie: Auf der Stelle treten! | Biopharma-Wertpapier verliert knapp 4% und setzt Negativtrend fort, während Experten überraschend ein Kurspotenzial von bis zu 500% prognostizieren. Die Veru-Aktie setzt ihren anhaltenden Abwärtstrend... ► Artikel lesen | |
TEMPEST THERAPEUTICS | 7,050 | 0,00 % | Tempest Therapeutics, Inc. - 8-K, Current Report | ||
VOLITIONRX | 0,536 | +13,13 % | VolitionRx Limited Announces Full Fiscal Year 2024 Financial Results and Business Update | Conference call to discuss financial and operational results scheduled for Monday, March 31 at 4:30 p.m. U.S. Eastern Time HENDERSON, Nevada, March 31, 2025 /PRNewswire/ -- VolitionRx... ► Artikel lesen | |
EKSO BIONICS | 0,350 | -2,23 % | Ekso Bionics Holdings Aktie: Beeindruckende Innovationskraft | Der Exoskelett-Hersteller verzeichnet im letzten Quartal 2024 Umsatzsteigerungen und Margenwachstum, kämpft jedoch mit Jahresrückgang bei hoher Aktienvolatilität. Ekso Bionics meldete für das vierte... ► Artikel lesen | |
IMUNON | 0,745 | -0,67 % | Imunon, Inc.: IMUNON Finalizes Phase 3 Study Design with FDA for IMNN-001 in Newly Diagnosed Advanced Ovarian Cancer | First and only immunotherapy to show meaningful overall survival benefit in a Phase 2 trial in patients with advanced ovarian cancer Initiation of trial sites underway for ground-breaking Phase 3... ► Artikel lesen | |
BEYOND AIR | 0,208 | -1,89 % | Beyond Air: NeuroNOS Appoints Nobel Prize Laureate, Professor Dan Shechtman, to Scientific Advisory Board | ||
AVINGER | 0,340 | -6,08 % | Avinger, Inc.: Avinger Reports Third Quarter 2024 Results | Lower Operating Cost Profile Drives Improved Productivity, Increased Gross Margin REDWOOD CITY, CA / ACCESSWIRE / November 7, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company... ► Artikel lesen | |
NOVACYT | 0,465 | -0,85 % | Novacyt S.A. - Liquidity Agreement and Total Voting Rights | ||
AROVELLA THERAPEUTICS | 0,052 | +16,85 % | Arovella tackles CAR-T's limitations in cancer treatment with off-the-shelf innovation |